CAL
CRMD icon

Capital Advisors Ltd’s CorMedix CRMD Stock Holding History

Capital Advisors Ltd’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+176
New +$1.39K ﹤0.01% 1200
2022
Q2 		– Sell
-51
Closed – – 1054
2022
Q1 		$0 Buy
+51
New +$234 ﹤0.01% 949

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Capital Advisors Ltd's CRMD Position: Q2 2026 in Review

Capital Advisors Ltd opened a new position in CorMedix (CRMD) in Q2 2026: 176 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1200 among its holdings. This is a return to the name: Capital Advisors Ltd previously reported a position in CRMD as recently as Q1 2022.

Capital Advisors Ltd first reported a position in CRMD in Q1 2022 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Capital Advisors Ltd held 176 shares of CorMedix worth $1K as of Q2 2026.
  • CorMedix was a new Capital Advisors Ltd position in Q2 2026.
  • CorMedix made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1200 holding.
  • Capital Advisors Ltd first reported a position in CorMedix in Q1 2022 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.